Lindner Center of HOPE 4075 Old Western Row Road Mason, OH 45040
Psychiatry
Dr. Paul E. Keck Jr., MD
|
|
Give Review
Paul Keck works in the field of Psychiatry. He researched medicine at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20/62 in Research/PrimaryCare. He received 3 awards: "Meaningful Use Stage 1 Certification", "Top MD" and "Whos Who in Medicine and Healthcare". Paul E. Keck Jr., MD is also a published doctor. He has 100 paper published. The most recent paper is: Psychopharmacologic treatment of eating disorders: emerging findings.
Publications
- Psychopharmacologic treatment of eating Disorders: emerging findings.
- Adjunctive lisdexamfetamine in Bipolar depression: a preliminary randomized, placebo-controlled trial.
- Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with Bipolar I disorder: a double-blind, placebo-controlled study.
- Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of Bipolar disorder.
- Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with Bipolar disorder.
- Monitoring pharmacotherapy response, safety, and tolerability to enhance adherence in Bipolar disorder.
- More Medical Comorbidities in Patients With Bipolar Disorder From the United States Than From the Netherlands and Germany.
- Metabolic syndrome in Bipolar disorder: a review with a focus on Bipolar depression.
- Placebo Response in Binge Eating Disorder: A Pooled Analysis of 10 Clinical Trials from One Research Group.
- Heritability and linkage analysis of personality in Bipolar disorder.
- Increased parental history of Bipolar disorder in the United States: association with early age of onset.
- More stressors prior to and during the course of Bipolar illness in patients from the United States compared with the Netherlands and Germany.
- Composite International Diagnostic Interview screening scales for DSM-IV Anxiety and mood disorders.
- Zonisamide in the treatment of bulimia nervosa: An open-label, pilot, prospective study.
- Heritability and genome-wide SNP linkage analysis of temperament in Bipolar disorder.
- Association of dopamine transporter gene variants with childhood ADHD features in Bipolar disorder.
- Role of childhood adversity in the development of medical co-morbidities associated with Bipolar disorder.
- Duloxetine in the treatment of binge eating Disorder with depressive Disorders: A placebo-controlled trial.
- Sodium oxybate in the treatment of binge eating Disorder: an open-label, prospective study.
- Acamprosate in the treatment of binge eating Disorder: a placebo-controlled trial.
- Complexity of pharmacologic treatment required for sustained improvement in outpatients with Bipolar disorder.
- Early-onset Bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
- Gender and depressive symptoms in 711 patients with Bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar treatment outcome network.
- Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory Bipolar spectrum disorder patients with moderate-to...
- Suggestive evidence for linkage of ADHD features in Bipolar disorder to chromosome 10p14.
- Memantine efficacy and safety in patients with acute mania associated with Bipolar I disorder: a pilot evaluation.
- Long-term safety and efficacy of ziprasidone in subpopulations of patients with Bipolar mania.
- Impact of antidepressant continuation after acute positive or partial treatment response for Bipolar depression: a blinded, randomized study.
- Correlates of treatment-emergent mania associated with antidepressant treatment in Bipolar depression.
- Treatment costs and health care utilization for patients with Bipolar disorder in a large managed care population.
- Clinical and economic effects of unrecognized or inadequately treated Bipolar disorder.
- Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in Bipolar disorder families.
- Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
- Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
- Bipolar depression: best practices for the outpatient.
- Bipolar depression: best practices for the hospitalized patient.
- Dopamine and serotonin receptor binding and antipsychotic efficacy.
- A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
- Treatment costs related to Bipolar disorder and comorbid conditions among Medicaid patients with Bipolar disorder.
- A placebo-controlled evaluation of adjunctive modafinil in the treatment of Bipolar depression.
- Neuroleptic malignant syndrome.
- The brain as a substrate for psychotropic therapeutics. Introduction.
- The poor prognosis of childhood-onset Bipolar disorder.
- Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
- Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight management.
- Atomoxetine in the treatment of binge-eating Disorder: a randomized placebo-controlled trial.
- Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with Bipolar disorder: a nested case-control study.
- Effects of co-occurring cannabis use disorders on the course of Bipolar disorder after a first hospitalization for mania.
- New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.
- Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
- Zonisamide in the treatment of binge eating Disorder with obesity: a randomized controlled trial.
- Long-term management strategies to achieve optimal function in patients with Bipolar disorder.
- The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood Disorders.
- Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of Bipolar depression and rapid cycling Bipolar disorder.
- Subsyndromal depressive symptoms are associated with functional impairment in patients with Bipolar disorder: results of a large, multisite study.
- Comorbidity of fibromyalgia and psychiatric Disorders.
- Risk of diabetes mellitus associated with atypical antipsychotic use among patients with Bipolar disorder: A retrospective, population-based, case-control study.
- A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of Bipolar I depression.
- A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of Bipolar depression.
- Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with Bipolar disorder.
- Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
- Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
- Risk of switch in mood polarity to hypomania or mania in patients with Bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropio...
- Lower switch rate in depressed patients with Bipolar II than Bipolar I disorder treated adjunctively with second-generation antidepressants.
- Pharmacologic treatment considerations in co-occurring bipolar and Anxiety disorders.
- Ethnic differences in maintenance antipsychotic prescription among adolescents with Bipolar disorder.
- Mixed hypomania in 908 patients with Bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.
- Ziprasidone in acute Bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
- Effects of co-occurring alcohol abuse on the course of Bipolar disorder following a first hospitalization for mania.
- Comparison of rapid-cycling and non-rapid-cycling Bipolar disorder based on prospective mood ratings in 539 outpatients.
- A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of Bipolar I or II depression.
- The Texas implementation of medication algorithms update for treatment of Bipolar I disorder.
- Reassessing carbamazepine in the treatment of Bipolar disorder: clinical implications of new data.
- Factors associated with medication adherence in African American and white patients with Bipolar disorder.
- Open-label adjunctive zonisamide in the treatment of Bipolar disorders: a prospective trial.
- Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of Bipolar depression.
- Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory Bipolar disorder.
- The role of second-generation antipsychotic monotherapy in the rapid control of acute Bipolar mania.
- Family study of fibromyalgia and affective spectrum Disorder.
- Predictors of response to treatment of acute Bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trials.
- Topiramate in the long-term treatment of binge-eating Disorder associated with obesity.
- Correlates of 1-year prospective outcome in Bipolar disorder: results from the Stanley Foundation Bipolar Network.
- Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
- Are mood Disorders and obesity related? A review for the mental health professional.
- Family study of fibromyalgia.
- Defining and improving response to treatment in patients with Bipolar disorder.
- Zonisamide in the treatment of binge-eating Disorder: an open-label, prospective trial.
- Evaluation and management of breakthrough Depressive episodes.
- A quality improvement process for implementing the Texas algorithm for schizophrenia in Ohio.
- Managing Metabolic Concerns in Patients with Severe Mental Illness. Introduction.
- Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
- Olanzapine versus placebo in acute mania: treatment responses in subgroups.
- Ethnicity and diagnosis in patients with affective Disorders.
- Impact of antidepressant discontinuation after acute Bipolar depression remission on rates of depressive relapse at 1-year follow-up.
- Maintenance efficacy of divalproex in the prevention of Bipolar depression.
- Psychosis in Bipolar disorder: phenomenology and impact on morbidity and course of illness.
- Citalopram in the treatment of binge-eating Disorder: a placebo-controlled trial.
- Morbidity in 258 Bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.
- Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in Bipolar disorder.
Schools
Mount Sinai School of Medicine
Beth Israel Med Center
McLean Hospital
Procedures Preformed
- Psychiatric Evaluation
Conditions Treated
- Anxiety
- Bipolar Disorder
- Borderline Personality Disorder
- Eating Disorders
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Choice Care PPO
- Preferred PPO
- Managed Care (Non-HMO)
- Medical Mutual of Ohio
- Medicare MCR
- Optima Health
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
- Top MD
- Whos Who in Medicine and Healthcare
Education
-
Mount Sinai Beth Israel -
Icahn School of Medicine at Mount Sinai
Helpful Reviews
Similar Doctors
|
|
Dr. Saba A. Chughtai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven F. Kendell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Crosby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy S. Cummings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jolomi T. Ikomi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle J. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan L. McElroy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne H. Sumida, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney M. Kassar, MD
This Doctor is OpenDoctor Recommended.
|